Search

everythinglearnresearchcommunity

for

Search:↓

High levels of the protein Flightless I worsen ulcerative colitis symptoms in mice.

Alopecia areata involves specific immune cells, offering potential treatment targets.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

Immortalized hair follicle cells could be useful for regenerative medicine and treating inflammation and oxidative stress.

IGF2BP3 and other m6A-related genes are linked to keloid formation and could be potential treatment targets.

Combined therapy reduces inflammation and restores immune balance in alopecia areata patients.

A specific group of immune and skin cells may cause chronic inflammation in atopic dermatitis.

Nuclear Factor I-C is important for controlling hair growth by affecting the TGF-β1 pathway.

Genetic differences affect COVID-19 severity and treatment effectiveness.

Upadacitinib improved multiple immune-related conditions in one patient.

Involucrin gene expression is controlled by specific proteins and signaling pathways.

Higher levels of IL-1a and IL-1RA were found in severe alopecia areata cases.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Oleuropein increases IGF-1 levels in mouse skin.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

JAK inhibitors show promise for treating various skin diseases.

The study found specific skin and cell changes in patients with monkeypox, helping diagnose and understand the disease.

Ulcerative colitis involves immune activation, chronic inflammation, and metabolic issues, some of which persist even during remission.

TLR3 activation helps improve skin and hair follicle healing in mice.

Ruxolitinib can cause a delayed skin reaction on the nose.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

Researchers developed a new way to measure gene activity in single hair follicles and found that a specific gene's activity changes with different amounts and times of treatment.

Enhancing CD8+ T cell function to induce ferroptosis in tumor cells may help treat skin melanoma.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Protein kinase C epsilon may increase skin cancer risk by affecting nearby cells.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.

Negative Pressure Wound Therapy speeds up wound healing by reducing inflammation and promoting skin cell growth.